Plunkett Research Online: Cocrystal Pharma Inc

COCRYSTAL PHARMA INC (COCP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first-and best.....



Cocrystal Pharma Inc
Ticker: COCP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 786-459-1831
Fax:
Address: 19805 North Creek Parkway
Bothell, WA 98011 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
Clinical-Stage Biopharmaceuticals
Therapeutic Development
Antiviral Drug Candidates
Viral Replication Inhibitors
Contacts Description
James MartinCFO/Chief Accounting Officer/Co-CEO
Roger KornbergChairman of the Board/Director
See More
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first-and best.....See More See More

Auditor: Weinberg & Company
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: